Noncompliant Coronary Balloon Helps Navigate Tortuous Anatomy
|
By HospiMedica International staff writers Posted on 15 Jun 2014 |
|
Image: The NC Euphora noncompliant balloon dilatation catheter with tapered tip (Photo courtesy Medtronic).
A new noncompliant coronary balloon provides superior deliverability and controlled growth in challenging angioplasty procedures.
The NC Euphora Noncompliant Balloon Dilatation Catheter offers enhanced deliverability through tight lesions via proprietary PowerTrac technology, thus requiring less force application to provide tracking through tortuous anatomy. An optimized tapered tip design and low lesion entry profile improve flexibility and allow for reliable stent re-cross when traversing long, challenging lesions, so that the balloon does not catch on a strut when passing through a deployed stent.
The balloon is made of strong, durable, and flexible Low Inflation Growth, High Track (LIGHT) material that provides high pressure capability, enabling the NC Euphora to expand consistently within the stent area at a rated burst pressure—the maximum pressure that the balloon can be repeatedly inflated in a safe manner—of up to 20 atmospheres without bursting. Significantly low radial growth reduces unwanted vessel expansion and longitudinal growth beyond the stent length, minimizing damage to the surrounding healthy artery. The NC Euphora Noncompliant Balloon Dilatation Catheter is a product of Medtronic (Minneapolis, MN, USA).
“NC Euphora expands our interventional portfolio with another clinically-relevant tool that was developed with both interventionalists and cath lab teams' needs in mind,” said Jason Weidman, vice president and general manager of Medtronic's coronary business. “With the addition of a premium noncompliant balloon, our interventional customers have a complement to the other innovative Medtronic offerings throughout the entire procedure for their most difficult and challenging cases.”
“When using a noncompliant balloon, deliverability and re-cross are important characteristics, especially when faced with challenging coronary anatomy,” said consultant interventional cardiologist Robert Gerber, MD, PhD, of Eastbourne District General Hospital East Sussex Healthcare NHS Trust, and preclinical researcher for the NC Euphora balloon. “The NC Euphora balloon was designed to meet these demands and provide reliable performance with no tradeoffs in the moment that we need it most.”
Related Links:
Medtronic
Eastbourne District General Hospital East Sussex Healthcare NHS Trust
The NC Euphora Noncompliant Balloon Dilatation Catheter offers enhanced deliverability through tight lesions via proprietary PowerTrac technology, thus requiring less force application to provide tracking through tortuous anatomy. An optimized tapered tip design and low lesion entry profile improve flexibility and allow for reliable stent re-cross when traversing long, challenging lesions, so that the balloon does not catch on a strut when passing through a deployed stent.
The balloon is made of strong, durable, and flexible Low Inflation Growth, High Track (LIGHT) material that provides high pressure capability, enabling the NC Euphora to expand consistently within the stent area at a rated burst pressure—the maximum pressure that the balloon can be repeatedly inflated in a safe manner—of up to 20 atmospheres without bursting. Significantly low radial growth reduces unwanted vessel expansion and longitudinal growth beyond the stent length, minimizing damage to the surrounding healthy artery. The NC Euphora Noncompliant Balloon Dilatation Catheter is a product of Medtronic (Minneapolis, MN, USA).
“NC Euphora expands our interventional portfolio with another clinically-relevant tool that was developed with both interventionalists and cath lab teams' needs in mind,” said Jason Weidman, vice president and general manager of Medtronic's coronary business. “With the addition of a premium noncompliant balloon, our interventional customers have a complement to the other innovative Medtronic offerings throughout the entire procedure for their most difficult and challenging cases.”
“When using a noncompliant balloon, deliverability and re-cross are important characteristics, especially when faced with challenging coronary anatomy,” said consultant interventional cardiologist Robert Gerber, MD, PhD, of Eastbourne District General Hospital East Sussex Healthcare NHS Trust, and preclinical researcher for the NC Euphora balloon. “The NC Euphora balloon was designed to meet these demands and provide reliable performance with no tradeoffs in the moment that we need it most.”
Related Links:
Medtronic
Eastbourne District General Hospital East Sussex Healthcare NHS Trust
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Digital Radiography System (Ceiling Free)
Digix CF Series
New
Patient Preoperative Skin Preparation
BD ChloraPrep
Latest Surgical Techniques News
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
- Fluorescence Probe Paired with Engineered Enzymes Lights Up Tumors for Easier Surgical Removal
- Novel Hydrogel Could Become Bone Implant of the Future
- Skull Implant Design Could Shape Surgical Outcomes
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Critical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
